ArticleJournal of experimental & clinical cancer research : CR2022

YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.